A series of studies chart a path for “gentler” care of blood cancers, questioning long-standing assumptions, the conference of the American Society of Hematology (ASH) has heard.
Dr Mikkael Sekeres, from the University of Miami, representing ASH,...
1 year ago
An analysis of the latest treatments for diffuse large B cell lymphoma (DLBCL) predicts high competition from a large number of upcoming drugs.
The data analytics company GlobalData says there are more than 255 products currently at the clinical t...
1 year ago
